{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:07:19Z","timestamp":1789985239312,"version":"4.0.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["nanomedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.nano.2014.08.005","type":"journal-article","created":{"date-parts":[[2014,9,5]],"date-time":"2014-09-05T09:58:23Z","timestamp":1409911103000},"page":"447-456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["A gold nanoparticle-linked glycoconjugate vaccine against Burkholderia mallei"],"prefix":"10.1016","volume":"11","author":[{"given":"Anthony E.","family":"Gregory","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara M.","family":"Judy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Qazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla A.","family":"Blumentritt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo G.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Titball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.nano.2014.08.005_bb0005","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s11095-012-0787-4","article-title":"Optimization of stability, encapsulation, release, and cross-priming of tumor antigen-containing PLGA nanoparticles","volume":"29","author":"Prasad","year":"2012","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.nano.2014.08.005_bb0010","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1021\/nn304235j","article-title":"Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-d,l-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses","volume":"7","author":"Zaric","year":"2013","journal-title":"ACS Nano"},{"issue":"44","key":"10.1016\/j.nano.2014.08.005_bb0015","doi-asserted-by":"crossref","first-page":"E989","DOI":"10.1073\/pnas.1104264108","article-title":"Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination","volume":"108","author":"Nembrini","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8\u20139","key":"10.1016\/j.nano.2014.08.005_bb0020","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/smll.200500104","article-title":"Cellular uptake and toxicity of Au55 clusters","volume":"1","author":"Tsoli","year":"2005","journal-title":"Small"},{"key":"10.1016\/j.nano.2014.08.005_bb0025","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/smll.200400093","article-title":"Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity","volume":"1","author":"Connor","year":"2005","journal-title":"Small"},{"issue":"11","key":"10.1016\/j.nano.2014.08.005_bb0030","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.addr.2008.03.013","article-title":"Biological properties of \u201cnaked\u201d metal nanoparticles","volume":"60","author":"Bhattacharya","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2014.08.005_bb0035","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2116\/analsci.24.907","article-title":"Gold nanoparticle-based surface enhanced raman scattering spectroscopic assay for the detection of protein\u2013protein interactions","volume":"24","author":"Li","year":"2008","journal-title":"Anal Sci"},{"issue":"8","key":"10.1016\/j.nano.2014.08.005_bb0040","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1021\/cr00016a002","article-title":"Large clusters and colloids. Metals in the embryonic state","volume":"92","author":"Schmid","year":"1992","journal-title":"Chem Rev"},{"issue":"11","key":"10.1016\/j.nano.2014.08.005_bb0045","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.1348-0421.1999.tb01238.x","article-title":"Stable marker on flagellin gene sequences related to arabinose non-assimilating pathogenic Burkholderia pseudomallei","volume":"43","author":"Wajanarogana","year":"1999","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.nano.2014.08.005_bb0050","article-title":"Federal experts security advisory panel, recommendations concerning the select agent program","author":"Korch","year":"2011"},{"issue":"2","key":"10.1016\/j.nano.2014.08.005_bb0055","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1574-6968.2007.00949.x","article-title":"Glanders: off to the races with Burkholderia mallei","volume":"277","author":"Whitlock","year":"2007","journal-title":"FEMS Microbiol Lett"},{"issue":"5","key":"10.1016\/j.nano.2014.08.005_bb0060","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1046\/j.1365-2958.1998.01139.x","article-title":"The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence","volume":"30","author":"DeShazer","year":"1998","journal-title":"Mol Microbiol"},{"issue":"3","key":"10.1016\/j.nano.2014.08.005_bb0065","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1128\/JB.184.3.849-852.2002","article-title":"Molecular and physical characterization of Burkholderia mallei O antigens","volume":"184","author":"Burtnick","year":"2002","journal-title":"J Bacteriol"},{"issue":"5","key":"10.1016\/j.nano.2014.08.005_bb0070","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1365-2958.2012.08154.x","article-title":"Aminoarabinose is essential for lipopolysaccharide export and intrinsic antimicrobial peptide resistance in Burkholderia cenocepacia \u2020","volume":"85","author":"Hamad","year":"2012","journal-title":"Mol Microbiol"},{"issue":"3","key":"10.1016\/j.nano.2014.08.005_bb0075","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1128\/IAI.74.3.1958-1961.2006","article-title":"Monoclonal antibodies passively protect BALB\/c mice against Burkholderia mallei aerosol challenge","volume":"74","author":"Trevi\u00f1o","year":"2006","journal-title":"Infect Immun"},{"issue":"47","key":"10.1016\/j.nano.2014.08.005_bb0080","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.1016\/j.vaccine.2010.08.058","article-title":"Lipopolysaccharide from Burkholderia thailandensis E264 provides protection in a murine model of melioidosis","volume":"28","author":"Ngugi","year":"2010","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.nano.2014.08.005_bb0085","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1099\/jmm.0.45766-0","article-title":"Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis","volume":"53","author":"Nelson","year":"2004","journal-title":"J Med Microbiol"},{"issue":"Suppl. 1","key":"10.1016\/j.nano.2014.08.005_bb0090","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/S0035-9203(08)70016-6","article-title":"Sero-characterization of lipopolysaccharide from Burkholderia thailandensis","volume":"102","author":"Qazi","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.nano.2014.08.005_bb0100","first-page":"249","article-title":"Conjugate vaccines\u2014a breakthrough in vaccine development","volume":"34","author":"Makela","year":"2003","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.nano.2014.08.005_bb0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1018500712733","article-title":"Chemical synthesis of Haemophilus influenzae glycopeptide conjugates","volume":"14","author":"Kandil","year":"1997","journal-title":"Glycoconj J"},{"issue":"2","key":"10.1016\/j.nano.2014.08.005_bb0110","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0022-3476(94)70328-0","article-title":"Immunogenicity and safety of Haemophilus influenzae type b-tetanus protein conjugate vaccine alone or mixed with diphtheria-tetanus-pertussis vaccine in infants","volume":"124","author":"Kaplan","year":"1994","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.nano.2014.08.005_bb0115","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/infdis\/161.5.821","article-title":"Polysaccharide\u2013protein conjugates: a new generation of vaccines","volume":"161","author":"Robbins","year":"1990","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.nano.2014.08.005_bb0120","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/00006454-199707000-00009","article-title":"Immune responses of infants vaccinated with serotype 6B pneumococcal polysaccharide conjugated with tetanus toxoid","volume":"16","author":"Sigurdardottir","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.nano.2014.08.005_bb0125","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1039\/df9511100055","article-title":"A study of the nucleation and growth processes in the synthesis of colloidal gold","volume":"11","author":"Turkevich","year":"1951","journal-title":"Discuss Faraday Soc"},{"issue":"5","key":"10.1016\/j.nano.2014.08.005_bb0130","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1046\/j.1365-2958.2000.02091.x","article-title":"Analysis of mutants of tetanus toxin HC fragment: ganglioside binding, cell binding and retrograde axonal transport properties","volume":"37","author":"Sinha","year":"2000","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.nano.2014.08.005_bb0135","series-title":"Methods in practical laboratory bacteriology","author":"Chart","year":"1994"},{"issue":"3","key":"10.1016\/j.nano.2014.08.005_bb0140","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1021\/ac60111a017","article-title":"Colorimetric method for determination of sugars and related substances","volume":"28","author":"DuBois","year":"1956","journal-title":"Anal Chem"},{"issue":"1","key":"10.1016\/j.nano.2014.08.005_bb0145","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ab.2004.12.001","article-title":"Carbohydrate analysis by a phenol\u2013sulfuric acid method in microplate format","volume":"339","author":"Masuko","year":"2005","journal-title":"Anal Biochem"},{"key":"10.1016\/j.nano.2014.08.005_bb0150","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0264-410X(96)00151-X","article-title":"Local and systemic immune response a microencapsulated sub-unit vaccine to for plague","volume":"14","author":"Williamson","year":"1996","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.nano.2014.08.005_bb0155","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.vaccine.2005.08.096","article-title":"Versatile and efficient synthesis of protein-polysaccharide conjugate vaccines using aminooxy reagents and oxime chemistry","volume":"24","author":"Lees","year":"2006","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.nano.2014.08.005_bb0160","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1021\/bc800153t","article-title":"Improved procedure for direct coupling of carbohydrates to proteins via reductive amination","volume":"19","author":"Gildersleeve","year":"2008","journal-title":"Bioconjug Chem"},{"issue":"39","key":"10.1016\/j.nano.2014.08.005_bb0165","doi-asserted-by":"crossref","first-page":"14246","DOI":"10.1073\/pnas.0403306101","article-title":"Structural flexibility in the Burkholderia mallei genome","volume":"101","author":"Nierman","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"39","key":"10.1016\/j.nano.2014.08.005_bb0170","doi-asserted-by":"crossref","first-page":"14240","DOI":"10.1073\/pnas.0403302101","article-title":"Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei","volume":"101","author":"Holden","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nano.2014.08.005_bb0175","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.micro.112408.134030","article-title":"Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis","volume":"64","author":"Galyov","year":"2010","journal-title":"Annu Rev Microbiol"},{"issue":"5","key":"10.1016\/j.nano.2014.08.005_bb0180","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1128\/CVI.00533-10","article-title":"In vitro and In vivo studies on monoclonal antibodies with prominent bactericidal activity against Burkholderia pseudomallei and Burkholderia mallei","volume":"18","author":"Zhang","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.nano.2014.08.005_bb0185","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1099\/0022-1317-51-12-1055","article-title":"Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide or proteins","volume":"51","author":"Jones","year":"2002","journal-title":"J Med Microbiol"},{"issue":"4","key":"10.1016\/j.nano.2014.08.005_bb0190","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1371\/journal.pone.0035386","article-title":"Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with Burkholderia pseudomallei","volume":"7","author":"AuCoin","year":"2012","journal-title":"PLoS One"},{"issue":"46","key":"10.1016\/j.nano.2014.08.005_bb0195","doi-asserted-by":"crossref","first-page":"8381","DOI":"10.1016\/j.vaccine.2011.08.058","article-title":"A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection","volume":"29","author":"Nieves","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.nano.2014.08.005_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090930","article-title":"Functional characterization and evaluation of in vitro protective efficacy of murine monoclonal antibodies BURK24 and BURK37 against Burkholderia pseudomallei","volume":"9","author":"Peddayelachagiri","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2014.08.005_bb0210","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1086\/520441","article-title":"Antilipopolysaccharide II: an antibody protective against fatal melioidosis","volume":"29","author":"Charuchaimontri","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.nano.2014.08.005_bb0215","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1128\/IAI.65.9.3648-3653.1997","article-title":"Specificity and functional activity of anti-Burkholderia pseudomallei polysaccharide antibodies","volume":"65","author":"Ho","year":"1997","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.nano.2014.08.005_bb0220","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2172-9-46","article-title":"Activation of Toll-like receptors by Burkholderia pseudomallei","volume":"9","author":"West","year":"2008","journal-title":"BMC Immunol"},{"issue":"2","key":"10.1016\/j.nano.2014.08.005_bb0225","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1128\/IAI.74.2.1113-1120.2006","article-title":"Flagellin Is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis","volume":"74","author":"Honko","year":"2006","journal-title":"Infect Immun"},{"issue":"42","key":"10.1016\/j.nano.2014.08.005_bb0230","doi-asserted-by":"crossref","first-page":"5875","DOI":"10.1016\/j.vaccine.2009.07.060","article-title":"Superior efficacy of a recombinant flagellin:H5N1 HA globular head vaccine is determined by the placement of the globular head within flagellin","volume":"27","author":"Song","year":"2009","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.nano.2014.08.005_bb0235","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/ni1011","article-title":"Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility","volume":"4","author":"Smith","year":"2003","journal-title":"Nat Immunol"},{"issue":"10","key":"10.1016\/j.nano.2014.08.005_bb0240","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1128\/IAI.68.10.5525-5529.2000","article-title":"High-affinity interaction between gram-negative flagellin and a cell surface polypeptide results in human monocyte activation","volume":"68","author":"McDermott","year":"2000","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.nano.2014.08.005_bb0245","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.mad.2008.01.009","article-title":"Mucosal adjuvant activity of flagellin in aged mice","volume":"129","author":"Bates","year":"2008","journal-title":"Mech Ageing Dev"},{"issue":"4","key":"10.1016\/j.nano.2014.08.005_bb0250","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.4049\/jimmunol.167.4.1882","article-title":"Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression","volume":"167","author":"Gewirtz","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2014.08.005_bb0255","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1128\/IAI.62.5.1914-1919.1994","article-title":"Isolation and characterization of Pseudomonas pseudomallei flagellin proteins","volume":"62","author":"Brett","year":"1994","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.nano.2014.08.005_bb0260","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1128\/IAI.64.1.283-289.1996","article-title":"Vibrio cholerae Hcp, a secreted protein coregulated with HlyA","volume":"64","author":"Williams","year":"1996","journal-title":"Infect Immun"},{"issue":"39","key":"10.1016\/j.nano.2014.08.005_bb0265","doi-asserted-by":"crossref","first-page":"15508","DOI":"10.1073\/pnas.0706532104","article-title":"Type VI secretion system translocates a phage tail spike-like protein into target cells where it cross-links actin","volume":"104","author":"Pukatzki","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.nano.2014.08.005_bb0275","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.provac.2010.03.013","article-title":"Protective response to subunit vaccination against intranasal Burkholderia mallei and B. pseudomallei challenge","volume":"2","author":"Whitlock","year":"2010","journal-title":"Procedia Vaccinol"},{"issue":"4","key":"10.1016\/j.nano.2014.08.005_bb0280","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/infdis\/jir301","article-title":"Combining vaccination and postexposure CpG therapy provides optimal protection against lethal sepsis in a biodefense model of human melioidosis","volume":"204","author":"Easton","year":"2011","journal-title":"J Infect Dis"},{"issue":"33","key":"10.1016\/j.nano.2014.08.005_bb0285","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1016\/j.vaccine.2009.05.040","article-title":"Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders","volume":"27","author":"Sarkar-Tyson","year":"2009","journal-title":"Vaccine"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963414004286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963414004286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T02:56:24Z","timestamp":1598237784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963414004286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1549963414004286"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2014.08.005","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A gold nanoparticle-linked glycoconjugate vaccine against Burkholderia mallei","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2014.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}